Public Profile

Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd, headquartered in Australia, is a pioneering biotechnology company focused on developing innovative radiopharmaceuticals for the treatment of cancer and other serious diseases. Founded in 2015, Clarity has rapidly established itself in the global healthcare landscape, particularly in the fields of targeted radiotherapy and diagnostic imaging. The company’s core products, including its proprietary radiopharmaceuticals, are designed to enhance the precision of cancer treatment while minimising side effects. Clarity's unique approach combines advanced imaging techniques with targeted therapies, positioning it as a leader in the radiopharmaceutical sector. With significant achievements in clinical trials and regulatory approvals, Clarity Pharmaceuticals continues to make strides in improving patient outcomes and advancing the future of cancer care.

DitchCarbon Score

How does Clarity Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

14

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Clarity Pharmaceuticals Ltd's score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Clarity Pharmaceuticals Ltd's reported carbon emissions

Clarity Pharmaceuticals Ltd, headquartered in Australia, currently does not have any publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in industry-standard practices aimed at sustainability and reducing environmental impact, which is increasingly important in the pharmaceutical sector. As the industry evolves, Clarity Pharmaceuticals may consider establishing measurable climate commitments and reduction initiatives to align with global sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Clarity Pharmaceuticals Ltd's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Clarity Pharmaceuticals Ltd is in AU, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Clarity Pharmaceuticals Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hengrui Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Blue Earth Diagnostics Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

RadioMedix, Inc.

US
Health and social work services (85)
Updated 3 days ago

University Of California, San Francisco

US
Health and social work services (85)
Updated 3 days ago

Curium Holding France

FR
Real estate services (70)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers